196 related articles for article (PubMed ID: 18926235)
1. Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
Frenckner B; Broomé M; Lindström M; Radell P
J Pediatr Surg; 2008 Oct; 43(10):1928-31. PubMed ID: 18926235
[TBL] [Abstract][Full Text] [Related]
2. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
Filan PM; McDougall PN; Shekerdemian LS
J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.
Keller RL; Hamrick SE; Kitterman JA; Fineman JR; Hawgood S
Pediatr Crit Care Med; 2004 Mar; 5(2):184-7. PubMed ID: 14987351
[TBL] [Abstract][Full Text] [Related]
4. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
[No Abstract] [Full Text] [Related]
5. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
7. Inhalation of nitric oxide as a treatment of pulmonary hypertension in congenital diaphragmatic hernia.
Henneberg SW; Jepsen S; Andersen PK; Pedersen SA
J Pediatr Surg; 1995 Jun; 30(6):853-5. PubMed ID: 7666321
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.
Chhina MK; Nargues W; Grant GM; Nathan SD
Future Cardiol; 2010 Jan; 6(1):19-35. PubMed ID: 20014985
[TBL] [Abstract][Full Text] [Related]
9. PDGF receptor and its antagonists: role in treatment of PAH.
Grimminger F; Schermuly RT
Adv Exp Med Biol; 2010; 661():435-46. PubMed ID: 20204747
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.
Minatsuki S; Miura I; Yao A; Abe H; Muraoka H; Tanaka M; Imamura T; Inaba T; Maki H; Hatano M; Kinugawa K; Yao T; Fukayama M; Nagai R; Komuro I
Int Heart J; 2015; 56(2):245-8. PubMed ID: 25740390
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil use in congenital diaphragmatic hernia.
Hunter L; Richens T; Davis C; Walker G; Simpson JH
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F467. PubMed ID: 19846401
[No Abstract] [Full Text] [Related]
12. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension.
Hatano M; Yao A; Shiga T; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2010 Jul; 51(4):272-6. PubMed ID: 20716845
[TBL] [Abstract][Full Text] [Related]
13. PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal.
Mathew R
Expert Opin Investig Drugs; 2012 Feb; 21(2):139-42. PubMed ID: 22217204
[No Abstract] [Full Text] [Related]
14. [Treatment with imatinib for refractory PAH].
Nakamura K; Akagi S; Sarashina T; Ogawa A; Matsubara H; Ito H
Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):173-7. PubMed ID: 24717604
[No Abstract] [Full Text] [Related]
15. Current pharmacological treatment of pulmonary arterial hypertension.
Steiropoulos P; Trakada G; Bouros D
Curr Clin Pharmacol; 2008 Jan; 3(1):11-9. PubMed ID: 18690874
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of pulmonary hypertension in infancy.
Steinhorn RH
Early Hum Dev; 2013 Nov; 89(11):865-74. PubMed ID: 24083892
[TBL] [Abstract][Full Text] [Related]
17. The role of imatinib in the treatment of pulmonary hypertension.
Mucke H
Drugs Today (Barc); 2013 Mar; 49(3):203-11. PubMed ID: 23527324
[TBL] [Abstract][Full Text] [Related]
18. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
Hoeper MM
Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
[No Abstract] [Full Text] [Related]
19. [Pulmonary hypertension and fetal circulation after severe congenital diaphragmatic hernia (author's transl)].
Mselati JC; Besson-Leaud M; Revillon Y; Laufenburger A; Lavaud J; Cloup M; Pellerin D
Chir Pediatr; 1979; 20(1):13-9. PubMed ID: 436190
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
